Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

<< Previous

Bullboard Posts

Next >>

Post by RazeKreationson Dec 23, 2021 2:00pm

210 Views

Post# 34258708

Very impressive results and many more to come

Now all we need is for the different stockhouses to update their financial reports for Microbix.
They still show earnings of -03.
when the updates are done then we need the analysts to update their forecasts as well. Then there will be some very good recomendations from Fund managers.
Very impressive results and many more to come.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments